by Elizabeth Kissling | Dec 18, 2009 | Health Care, Law/Legal, Menopause, Pharmaceutical
You may have heard the news that 23 hormone replacement therapy lawsuits filed by women diagnosed with breast cancer were dismissed by a New York judge this week. Judge Martin Shulman granted Pfizer’s motion to dismiss for two reasons: the plaintiff’s...
by Elizabeth Kissling | Dec 13, 2009 | Advertising, Law/Legal, Media, Menopause
There’s a pretty good essay in this weekend’s New York Times (online here Saturday, in print Sunday in the Business section) about how hard Big Pharma has worked to market menopause as an estrogen deficiency disease. In addition to discussion of...
by Elizabeth Kissling | Dec 11, 2009 | Girls, Health Care, Law/Legal, New Research, Pharmaceutical
Today I want to point to two important articles about women’s health from our friends at Women’s eNews: Yesterday, they published a story about Myriad Genetics and their firm grasp on the patents for diagnostics tests for BRCA1 and BRCA2 genes, which are...
by Laura Wershler | Dec 10, 2009 | Birth Control, Health Care, Media, Menarche, Menopause, Menstruation, Newspapers, Ovulation
Can having too many menstrual cycles give you breast cancer? That’s what one might conclude from two unrelated articles that appeared in national newspapers this week. First was Nicholas D. Kristof’s Op-Ed in the New York Times. Kristof had recently...
by Elizabeth Kissling | Dec 8, 2009 | Law/Legal, Menopause, Pharmaceutical
Here’s one way that Canada shows some concern for risks to women’s health: the owner of a New Brunswick health food store was fined $7500 for smuggling a progesterone-laced cream from the U.S. The cream, called Aim Renewed Balance, is purported “to...
